MitoNeoD, a mitochondria-targeted hydroethidine analogue introduced in 2017, enables assessment of mitochondrial superoxide (O2∙−O_2^{\bullet-}) by fluorescence in vitro and by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) quantification of its superoxide-derived product MitoNeoOH in vivo, but its own authors listed three limitations and acknowledged a fourth concern without quantifying it: (i) each in vivo time point requires destructive tissue extraction, precluding continuous or longitudinal monitoring; (ii) the radical-cation intermediate leading to MitoNeoOH can be generated by one-electron oxidants other than O2∙−O_2^{\bullet-}, so other oxidants could elevate the signal without a change in superoxide; (iii) measurement outside mitochondria via the untargeted analogue NeoD was deferred to future work; and (iv) dimeric oxidation side products and their effect on quantification were not assessed, although a deuterated dimer internal standard was prepared for potential dimer formation. None of these four concerns has been resolved to date: mechanism-level kinetics for the parent hydroethidine family have clarified, but not measured away, the oxidant-interference concern; NeoD remains an unvalidated compound rather than a developed assay; dimer formation in biological samples has never been quantified; and in vivo superoxide measurement remains endpoint-based and destructive. The open problem is to complete the development of this probe class into a superoxide-specific, compartment-resolved, quantitatively robust, and non-destructive methodology.

Background

Superoxide (O2∙−O_2^{\bullet-}), the one-electron reduction product of oxygen, is produced in the mitochondrial matrix by the respiratory chain and is implicated in oxidative damage and redox signaling, so measuring it in living systems is a long-standing goal of redox biology. The classical fluorescent probe hydroethidine (HE, also called dihydroethidium) and its mitochondria-targeted derivative MitoSOX Red are oxidized to fluorescent cations, but this fluorescence is not specific for O2∙−O_2^{\bullet-}: non-specific one-electron oxidation produces ethidium-type cations, whereas reaction with O2∙−O_2^{\bullet-} produces a distinctive 2-hydroxylated cation, and distinguishing the two requires chromatographic separation by high-performance liquid chromatography (HPLC) or HPLC coupled to mass spectrometry (LC-MS); ethidium-type products also intercalate into DNA, which artificially enhances their fluorescence. MitoNeoD was designed to overcome these defects: it is a reduced phenanthridinium bearing bulky neopentylamino groups that block DNA intercalation, a carbon–deuterium bond at the oxidation site that slows non-specific background oxidation (a kinetic isotope effect) more than the O2∙−O_2^{\bullet-}-specific reaction, and a triphenylphosphonium (TPP) cation — a lipophilic permanently charged group that drives accumulation of the probe in polarized mitochondria. In vivo, MitoNeoD is deployed by the 'exomarker' approach: the probe is injected into a living animal, reacts within mitochondria to form MitoNeoOH, and the tissue is then extracted so that MitoNeoOH and the non-specific oxidation product MitoNeo are quantified by LC-MS/MS against deuterated internal standards, with the ratiometric readout correcting for variable probe uptake. This made it possible, for the first time, to assess changes in mitochondrial O2∙−O_2^{\bullet-} in vivo (demonstrated in mouse heart). The source paper itself, however, states three limitations of the method and leaves a fourth concern unquantified. First, the exomarker assay is destructive: every time point requires sacrificing tissue, so no continuous or longitudinal monitoring of superoxide within one animal is possible. Second, the chemical step that precedes product formation is oxidation of MitoNeoD to a radical cation, and radical cations of hydroethidine-family probes can be generated by many one-electron oxidants (hydroxyl, peroxyl, carbonate, nitrogen dioxide, glutathionyl and cysteinyl radicals); because this radical cation is on the pathway to the 2-hydroxylated product, an elevation of such oxidants could in principle raise the apparent superoxide signal without any change in O2∙−O_2^{\bullet-} itself. Third, only the mitochondria-targeted member of the family was developed; the untargeted analogue NeoD (the same reporter without the TPP group, expected to report on cytosolic and other non-mitochondrial superoxide) was synthesized and shown to react with O2∙−O_2^{\bullet-} in vitro, but its biological application was deferred to future work. Fourth, hydroethidine-family probes can dimerize through their radical cations; a deuterated MitoNeo dimer was prepared as an internal standard for potential dimer formation, but no quantitative assessment of dimer side products or their effect on the ratiometric quantification was reported. Authoritative later guidance (the 2022 Nature Metabolism guidelines on measuring reactive oxygen species) still recommends chromatographic product separation, lists NeoD/MitoNeoD merely as DNA-intercalation-free variants, and leaves in vivo superoxide measurement an unmet need.

Problem Statement

Complete the development of the MitoNeoD/NeoD probe class into a superoxide-specific, compartment-resolved, and quantitatively robust methodology for measuring O2∙−O_2^{\bullet-} in living systems, resolving the three limitations stated by the probe's originators together with the dimer concern they acknowledged but did not quantify: (1) Oxidant specificity — characterize the oxidation of MitoNeoD and NeoD themselves by the biologically relevant one-electron oxidants (e.g., hydroxyl, peroxyl, carbonate, nitrogen dioxide, glutathionyl and cysteinyl radicals), and establish how much these oxidants can elevate the apparent MitoNeoOH/NeoOH signal at unchanged O2∙−O_2^{\bullet-}, together with a validated way to distinguish a true change in superoxide from a change in other one-electron oxidants. (2) Compartment extension — develop and validate the untargeted analogue NeoD as a quantitative probe of superoxide production outside mitochondria (e.g., cytosol), including probe delivery and retention, product identification and separation, and a quantification scheme, with demonstration in cells. (3) Dimeric side products — measure whether MitoNeoD/NeoD and their radical cations form dimeric products in vitro and in biological samples, and quantify the impact of any such dimers on the LC-MS/MS and fluorescence readouts (or demonstrate experimentally that the contribution is negligible under assay conditions). (4) Non-destructive in vivo monitoring — enable repeated or continuous in vivo assessment of superoxide within the same animal, superseding the destructive single-time-point tissue extraction, while preserving superoxide selectivity and mitochondrial (or, via NeoD, compartment) resolution. The four parts are independent sub-questions that are jointly posed toward one overarching objective: quantitative, selective, compartment- and time-resolved superoxide measurement in living systems.

References

  1. Shchepinova M. M., Cairns A. G., Prime T. A., Logan A., James A. M., Hall A. R., Vidoni S., Arndt S., Caldwell S. T., Prag H. A., Pell V. R., Krieg T., Mulvey J. F., Yadav P., Cobley J. N., Bright T. P., Senn H. M., Anderson R. F., Murphy M. P., Hartley R. C. MitoNeoD: A Mitochondria-Targeted Superoxide Probe. Cell Chemical Biology 24(10):1285–1298.e12, 2017. doi:10.1016/j.chembiol.2017.08.003. https://doi.org/10.1016/j.chembiol.2017.08.003 (PMC6278870)
  2. Kalyanaraman B., Dranka B. P., Hardy M., Michalski R., Zielonka J. HPLC-based monitoring of products formed from hydroethidine-based fluorogenic probes — The ultimate approach for intra- and extracellular superoxide detection. Biochimica et Biophysica Acta — General Subjects 1840(2):739–744, 2014. doi:10.1016/j.bbagen.2013.05.008. https://doi.org/10.1016/j.bbagen.2013.05.008
  3. Michalski R., Thiebaut D., Michałowski B., Ayhan M. M., Hardy M., Ouari O., Rostkowski M., Smulik-Izydorczyk R., Artelska A., Marcinek A., Zielonka J., Kalyanaraman B., Sikora A. Oxidation of ethidium-based probes by biological radicals: mechanism, kinetics and implications for the detection of superoxide. Scientific Reports 10:18626, 2020. doi:10.1038/s41598-020-75373-2. https://doi.org/10.1038/s41598-020-75373-2 (PMC7596101)
  4. Murphy M. P., Bayir H., Belousov V., Chang C. J., Davies K. J. A., Davies M. J., Dick T. P., Finkel T., Forman H. J., Janssen-Heininger Y., Gems D., Kagan V. E., Kalyanaraman B., Larsson N.-G., Milne G. L., Nyström T., Poulsen H. E., Radi R., Van Remmen H., Schumacker P. T., Thornalley P. J., Toyokuni S., Winterbourn C. C., Yin H., Halliwell B. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nature Metabolism 4(6):651–662, 2022. doi:10.1038/s42255-022-00591-z. https://doi.org/10.1038/s42255-022-00591-z (PMC9711940)
  5. García S., Carmona-Santiago G., Jiménez-Sánchez A. Redefining Molecular Probes for Monitoring Subcellular Environment: A Perspective. Analytical Chemistry 96(49):19183–19189, 2024. doi:10.1021/acs.analchem.4c05022. https://doi.org/10.1021/acs.analchem.4c05022 (PMC11635757)
  6. Casey A. M., Ryan D. G., Prag H. A., Roy Chowdhury S., Marques E., Turner K., Gruszczyk A. V., Yang M., Wolf D. M., Miljkovic J. L., Valadares J., Chinnery P. F., Hartley R. C., Frezza C., Prudent J., Murphy M. P. Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1β release during NLRP3 inflammasome activation. Nature Metabolism 7(3):493–507, 2025. doi:10.1038/s42255-025-01224-x. https://doi.org/10.1038/s42255-025-01224-x (PMC11946910)
  7. Weinberg S. E., Chandel N. S. Mitochondria reactive oxygen species signaling in immune responses. Immunity 58(8):1904–1921, 2025. doi:10.1016/j.immuni.2025.07.012. https://doi.org/10.1016/j.immuni.2025.07.012 (PMC12371701)
  8. Wilde J. H., Sun Y.-Y., Simpson S. R., Hill E. R., Fu Z., Bian E. J., Kinkaid M. M., Villanueva P., Weybright A. F., Terrell W. R., Qureshi Z., Perera S. S., Sheppard H. S., Stone J. R., Kundu B. K., Kuan C.-Y., Neumann K. D. A positron emission tomography tracer for the imaging of oxidative stress in the central nervous system. Nature Biomedical Engineering 9:716–729, 2025. doi:10.1038/s41551-025-01362-3. https://doi.org/10.1038/s41551-025-01362-3
  9. Karges J. Reactive Oxygen Species Detection with Fluorescent Probes: Limitations and Recommendations beyond DCFH-DA. Journal of Medicinal Chemistry 69(3):1970–1981, 2026. doi:10.1021/acs.jmedchem.5c03494. https://doi.org/10.1021/acs.jmedchem.5c03494